Robert M Kunemund
Examiner (ID: 4089)
Most Active Art Unit | 1714 |
Art Unit(s) | 1107, 1765, 1714, 1792, 1722, 1109, 1103, 1763 |
Total Applications | 3442 |
Issued Applications | 2671 |
Pending Applications | 149 |
Abandoned Applications | 593 |
Applications
Application number | Title of the application | Filing Date | Status |
---|---|---|---|
Array
(
[id] => 18947051
[patent_doc_number] => 11890324
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-02-06
[patent_title] => Compounds for use in inducing myocardial perfusion recovery
[patent_app_type] => utility
[patent_app_number] => 17/309720
[patent_app_country] => US
[patent_app_date] => 2019-12-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 9
[patent_no_of_words] => 6815
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 64
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17309720
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/309720 | Compounds for use in inducing myocardial perfusion recovery | Dec 19, 2019 | Issued |
Array
(
[id] => 15768801
[patent_doc_number] => 20200115418
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-04-16
[patent_title] => ANTI-HIV PEPTIDES
[patent_app_type] => utility
[patent_app_number] => 16/723164
[patent_app_country] => US
[patent_app_date] => 2019-12-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 25534
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 37
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16723164
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/723164 | Anti-HIV peptides | Dec 19, 2019 | Issued |
Array
(
[id] => 17458802
[patent_doc_number] => 20220072106
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-03-10
[patent_title] => DECORIN FOR ITS USE IN THE TREATMENT OF DIABETES
[patent_app_type] => utility
[patent_app_number] => 17/416130
[patent_app_country] => US
[patent_app_date] => 2019-12-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21652
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 24
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17416130
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/416130 | DECORIN FOR ITS USE IN THE TREATMENT OF DIABETES | Dec 18, 2019 | Pending |
Array
(
[id] => 16533308
[patent_doc_number] => 10875891
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-12-29
[patent_title] => Short synthetic peptide and uses thereof
[patent_app_type] => utility
[patent_app_number] => 16/719952
[patent_app_country] => US
[patent_app_date] => 2019-12-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 10230
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 39
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16719952
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/719952 | Short synthetic peptide and uses thereof | Dec 17, 2019 | Issued |
Array
(
[id] => 16695496
[patent_doc_number] => 10946065
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-03-16
[patent_title] => Methods of treating fungal infections
[patent_app_type] => utility
[patent_app_number] => 16/717726
[patent_app_country] => US
[patent_app_date] => 2019-12-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 9681
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 61
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16717726
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/717726 | Methods of treating fungal infections | Dec 16, 2019 | Issued |
Array
(
[id] => 16360990
[patent_doc_number] => 20200317741
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-10-08
[patent_title] => COMPOSITION FOR PREVENTING HAIR LOSS OR PROMOTING HAIR GROWTH
[patent_app_type] => utility
[patent_app_number] => 16/676393
[patent_app_country] => US
[patent_app_date] => 2019-11-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4267
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16676393
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/676393 | Composition for preventing hair loss or promoting hair growth | Nov 5, 2019 | Issued |
Array
(
[id] => 17398170
[patent_doc_number] => 20220040260
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-02-10
[patent_title] => ANTIEPILEPTIC TOXIN MARTENTOXIN AND USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/291016
[patent_app_country] => US
[patent_app_date] => 2019-11-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9350
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 30
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17291016
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/291016 | ANTIEPILEPTIC TOXIN MARTENTOXIN AND USE THEREOF | Nov 4, 2019 | Pending |
Array
(
[id] => 18383333
[patent_doc_number] => 11654097
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-05-23
[patent_title] => Peptide having activities of skin whitening and uses thereof
[patent_app_type] => utility
[patent_app_number] => 16/625865
[patent_app_country] => US
[patent_app_date] => 2019-10-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 12
[patent_no_of_words] => 4835
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 33
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16625865
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/625865 | Peptide having activities of skin whitening and uses thereof | Oct 9, 2019 | Issued |
Array
(
[id] => 17227152
[patent_doc_number] => 20210353708
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-11-18
[patent_title] => Brevican-Binding Peptides for Brain Tumor Imaging
[patent_app_type] => utility
[patent_app_number] => 17/282028
[patent_app_country] => US
[patent_app_date] => 2019-10-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20916
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17282028
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/282028 | Brevican-Binding Peptides for Brain Tumor Imaging | Sep 30, 2019 | Pending |
Array
(
[id] => 16998381
[patent_doc_number] => 11077163
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-08-03
[patent_title] => Peptide for treating ocular diseases and composition for treating ocular diseases comprising same
[patent_app_type] => utility
[patent_app_number] => 16/582014
[patent_app_country] => US
[patent_app_date] => 2019-09-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 6
[patent_no_of_words] => 6416
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 33
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16582014
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/582014 | Peptide for treating ocular diseases and composition for treating ocular diseases comprising same | Sep 24, 2019 | Issued |
Array
(
[id] => 18013298
[patent_doc_number] => 11505580
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-11-22
[patent_title] => Leech polypeptide and use thereof
[patent_app_type] => utility
[patent_app_number] => 16/770026
[patent_app_country] => US
[patent_app_date] => 2019-09-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 13
[patent_no_of_words] => 4977
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16770026
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/770026 | Leech polypeptide and use thereof | Sep 23, 2019 | Issued |
Array
(
[id] => 17226395
[patent_doc_number] => 20210352951
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-11-18
[patent_title] => COMPOSITIONS AND METHODS FOR TREATMENT OF EXOCRINE PANCREATIC INSUFFICIENCY (EPI)
[patent_app_type] => utility
[patent_app_number] => 17/277586
[patent_app_country] => US
[patent_app_date] => 2019-09-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8509
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17277586
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/277586 | COMPOSITIONS AND METHODS FOR TREATMENT OF EXOCRINE PANCREATIC INSUFFICIENCY (EPI) | Sep 19, 2019 | Pending |
Array
(
[id] => 15711169
[patent_doc_number] => 20200102350
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-04-02
[patent_title] => PEPTIDE THAT REGULATES FAT METABOLISM AND METHOD FOR REGULATING FAT METABOLISM
[patent_app_type] => utility
[patent_app_number] => 16/572584
[patent_app_country] => US
[patent_app_date] => 2019-09-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7532
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 140
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16572584
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/572584 | Peptide that regulates fat metabolism and method for regulating fat metabolism | Sep 15, 2019 | Issued |
Array
(
[id] => 15589671
[patent_doc_number] => 20200071370
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-03-05
[patent_title] => CELL PENETRATING PEPTIDES THAT INHIBIT IRF5 NUCLEAR LOCALIZATION
[patent_app_type] => utility
[patent_app_number] => 16/570291
[patent_app_country] => US
[patent_app_date] => 2019-09-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14069
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16570291
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/570291 | Cell penetrating peptides that inhibit IRF5 nuclear localization | Sep 12, 2019 | Issued |
Array
(
[id] => 15342689
[patent_doc_number] => 20200009236
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-01-09
[patent_title] => H3.3 CTL Peptides and Uses Thereof
[patent_app_type] => utility
[patent_app_number] => 16/569615
[patent_app_country] => US
[patent_app_date] => 2019-09-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15973
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 76
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16569615
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/569615 | H3.3 CTL peptides and uses thereof | Sep 11, 2019 | Issued |
Array
(
[id] => 17250107
[patent_doc_number] => 11185577
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-11-30
[patent_title] => H3.3 CTL peptides and uses thereof
[patent_app_type] => utility
[patent_app_number] => 16/569613
[patent_app_country] => US
[patent_app_date] => 2019-09-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 28
[patent_no_of_words] => 15990
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 100
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16569613
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/569613 | H3.3 CTL peptides and uses thereof | Sep 11, 2019 | Issued |
Array
(
[id] => 17398180
[patent_doc_number] => 20220040270
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-02-10
[patent_title] => AGENT AND COMPOSITION FOR IMPROVING INTRAUTERINE BACTERIAL FLORA, AND METHOD FOR DETERMINING WHETHER INTRAUTERINE BACTERIAL FLORA HAS BEEN IMPROVED OR NORMALIZED
[patent_app_type] => utility
[patent_app_number] => 17/278619
[patent_app_country] => US
[patent_app_date] => 2019-09-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6495
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -6
[patent_words_short_claim] => 20
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17278619
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/278619 | AGENT AND COMPOSITION FOR IMPROVING INTRAUTERINE BACTERIAL FLORA, AND METHOD FOR DETERMINING WHETHER INTRAUTERINE BACTERIAL FLORA HAS BEEN IMPROVED OR NORMALIZED | Sep 10, 2019 | Pending |
Array
(
[id] => 16206541
[patent_doc_number] => 20200239531
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-07-30
[patent_title] => CONJUGATED KNOTTIN MINI-PROTEINS CONTAINING NON-NATURAL AMINO ACIDS
[patent_app_type] => utility
[patent_app_number] => 16/565243
[patent_app_country] => US
[patent_app_date] => 2019-09-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10633
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16565243
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/565243 | Conjugated knottin mini-proteins containing non-natural amino acids | Sep 8, 2019 | Issued |
Array
(
[id] => 18428717
[patent_doc_number] => 11673927
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-06-13
[patent_title] => Antitumor agent targeting HGF-regulated tyrosine kinase substrate (HGS)
[patent_app_type] => utility
[patent_app_number] => 17/271088
[patent_app_country] => US
[patent_app_date] => 2019-08-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 11
[patent_no_of_words] => 9467
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 87
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17271088
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/271088 | Antitumor agent targeting HGF-regulated tyrosine kinase substrate (HGS) | Aug 27, 2019 | Issued |
Array
(
[id] => 15556787
[patent_doc_number] => 20200062805
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-02-27
[patent_title] => Cell-Permeable Peptide Inhibitors of the JNK Signal Transduction Pathway
[patent_app_type] => utility
[patent_app_number] => 16/525234
[patent_app_country] => US
[patent_app_date] => 2019-07-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19811
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16525234
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/525234 | Cell-Permeable Peptide Inhibitors of the JNK Signal Transduction Pathway | Jul 28, 2019 | Abandoned |